BioLargo, Inc.
BLGO
$0.16
$0.00-1.82%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.78M | -9.84M | -3.90M | -3.15M | -2.40M |
| Total Depreciation and Amortization | 406.00K | 336.00K | 301.00K | 299.00K | 255.00K |
| Total Amortization of Deferred Charges | 196.00K | 106.00K | 67.00K | 28.00K | -- |
| Total Other Non-Cash Items | 3.88M | 4.05M | -64.00K | 155.00K | 479.00K |
| Change in Net Operating Assets | -998.00K | -3.27M | -3.89M | -2.85M | -1.54M |
| Cash from Operations | -8.30M | -8.62M | -7.48M | -5.52M | -3.21M |
| Capital Expenditure | -46.00K | -8.00K | -14.00K | -372.00K | -1.24M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 481.00K | 399.00K | 110.00K | -82.00K | -82.00K |
| Cash from Investing | 435.00K | 391.00K | 96.00K | -454.00K | -1.32M |
| Total Debt Issued | 1.29M | 2.18M | 2.18M | 1.45M | 864.00K |
| Total Debt Repaid | 0.00 | -20.00K | -15.00K | -13.00K | -14.00K |
| Issuance of Common Stock | 4.79M | 4.56M | 3.90M | 2.80M | 3.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.15M | 2.15M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -15.00K | -- |
| Cash from Financing | 8.22M | 8.86M | 6.06M | 4.22M | 4.44M |
| Foreign Exchange rate Adjustments | -24.00K | 35.00K | 39.00K | -22.00K | 94.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 335.00K | 664.00K | -1.29M | -1.77M | 9.00K |